Published in Nutr J on January 26, 2009
Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry (2010) 1.37
The gut microbiome and the brain. J Med Food (2014) 1.06
Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open (2014) 0.90
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome (2016) 0.88
Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) (2010) 0.85
A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology (2012) 0.80
Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med (2011) 0.77
Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study. Sleep Sci (2015) 0.76
Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes. Integr Med (Encinitas) (2017) 0.75
A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition. Am J Case Rep (2016) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain (1997) 5.29
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology (2002) 4.40
The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2001) 2.38
Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol (1997) 2.26
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 2.00
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis (2000) 1.83
Probiotics and gastrointestinal diseases. J Intern Med (2005) 1.47
Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res (2000) 1.40
Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol (1999) 1.33
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci (2002) 1.32
The epidemiology of chronic fatigue in the Swedish Twin Registry. Psychol Med (2005) 1.31
Antioxidative ability of lactic acid bacteria. J Agric Food Chem (1999) 1.25
Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr (2003) 1.23
Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev (2005) 1.14
Epidemiology of chronic fatigue syndrome. Occup Med (Lond) (2005) 1.13
Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev (2001) 1.13
A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr (2002) 1.09
Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci (2001) 1.07
The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Psychosom Med (2005) 1.06
Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses (2003) 0.97
Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol (1996) 0.96
Chronic fatigue syndrome: probable pathogenesis and possible treatments. Drugs (2002) 0.94
Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol (2001) 0.88
Chronic fatigue syndrome (cfs). Swiss Med Wkly (2004) 0.80
Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora. J Antimicrob Chemother (2004) 0.79
Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. Scand J Gastroenterol (2007) 0.79
Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med (2006) 1.49
Importance of genetic influences on chronic widespread pain. Arthritis Rheum (2006) 1.41
Premorbid predictors of chronic fatigue. Arch Gen Psychiatry (2006) 1.40
Indicators of food and water security in an Arctic Health context--results from an international workshop discussion. Int J Circumpolar Health (2013) 1.38
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One (2012) 1.34
Physiological correlates of burnout among women. J Psychosom Res (2003) 1.29
Facing the limit of resilience: perceptions of climate change among reindeer herding Sami in Sweden. Glob Health Action (2011) 1.23
Twin analyses of chronic fatigue in a Swedish national sample. Psychol Med (2005) 1.18
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob Agents Chemother (2004) 1.13
Chronic fatigue in a population sample: definitions and heterogeneity. Psychol Med (2005) 1.12
The gender perspective in climate change and global health. Glob Health Action (2010) 1.07
DNA extraction and PCR assays for detection of Toxoplasma gondii. APMIS (2004) 1.06
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS (2008) 1.05
Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage (2002) 1.05
Connecting the global climate change and public health agendas. PLoS Med (2012) 0.93
"The Laundry Bag Project"--unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol (2008) 0.92
Climate change, its impact on human health in the Arctic and the public health response to threats of emerging infectious diseases. Glob Health Action (2009) 0.91
Toxoplasmosis in immunocompromized patients. Scand J Infect Dis (2009) 0.88
An unbiased metagenomic search for infectious agents using monozygotic twins discordant for chronic fatigue. BMC Microbiol (2011) 0.87
Travel health advice: benefits, compliance, and outcome. Scand J Infect Dis (2014) 0.86
The influence of seasonal climate variability on mortality in pre-industrial Sweden. Glob Health Action (2013) 0.84
Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome. J Clin Pathol (2006) 0.84
A call for urgent monitoring of food and water security based on relevant indicators for the Arctic. Ambio (2013) 0.80
Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. Scand J Gastroenterol (2007) 0.79
Gene expression of estrogen receptors in PBMC from patients with Puumala virus infection. Shock (2012) 0.79
Possible influence of defenses and negative life events on patients with chronic fatigue syndrome: a pilot study. Psychol Rep (2002) 0.78
Travel and vaccination patterns: a report from a travel medicine clinic in northern Sweden. Scand J Infect Dis (2011) 0.78
Evaluation of rapid diagnostic tests for malaria in Swedish travellers. APMIS (2010) 0.77
[The laundry-basket project--gender differences to the very skin. Different treatment of some common skin diseases in men and women]. Lakartidningen (2005) 0.77
[In Process Citation]. Lakartidningen (2015) 0.75
[Rapid malaria tests--good complement to microscopy. High sensitivity for Plasmodium falciparum in Swedish travellers]. Lakartidningen (2011) 0.75
Toxoplasmosis not transmitted by cat bite, but high prevalence of antibodies to Toxoplasma gondii in patients bitten by their own cat. Scand J Infect Dis (2010) 0.75
beta-Alanine and gamma-aminobutyric acid in chronic fatigue syndrome. Clin Chim Acta (2006) 0.75
[Emotional exhaustion common among women in the public sector]. Lakartidningen (2002) 0.75